Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Epilepsy
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent webcasts/CME - Epilepsy
Case in Point: Evidence-Based Insights For Epilepsy Management - Comorbid Depressive Disorders in Epilepsy

Webcasts/CME archive

 Recent news - Epilepsy
    Responsive Brain Stimulation Safe and Effective for Treatment of Medically Intractable Seizures in Adults - (DGDispatch)
    Prevalence of Electrographic Seizures After Convulsive Status Epilepticus Clarified in Children - (DGDispatch)
    Eslicarbazepine Acetate Is Safe Adjunctive Therapy for Refractory Partial-Onset Epilepsy Seizures - (DGDispatch)
    Patients Should Be Monitored for Aggression During Perampanel Treatment - (DGDispatch)
    Lacosamide Monotherapy Efficacious for Treatment of Partial-Onset Seizures - (DGDispatch)

    News archive

     Recent cases - Epilepsy
      Takayasu's Disease Presenting As Convulsive Syncope Which Had Been Misinterpreted As Epilepsy: A Case Report
      Treatment Of Refractory Epilepsy With Natalizumab In A Patient With Multiple Sclerosis. Case Report
      Partial Motor Status Epilepticus As A Clinical Manifestation Of Carotid Stenosis
      Ilizarov Treatment Of Humeral Shaft Nonunion In An Antiepileptic Drug Patient With Uncontrolled Generalized Tonic-Clonic Seizure Activity
      B Cell Aplasia and Hypogammaglobulinemia after Carbamazepine Treatment

      Cases archive
        




      personal edition > epilepsy > webcasts/CME
      divider
      Webcasts/CME


        E-Mail this webcast/CME to a colleague




      news Pharmacoresistant Epilepsy: From Pathogenesis To Current And Emerging Therapies

      Presented by:The Cleveland Clinic Foundation Center for Continuing Education
      LecturerBrian F. Mandell, MD, PhD, Timothy Gilligan, MD, Sandipan Pati, MD and Andreas V. Alexopoulos, MD, MPH
      Approximate duration:Not available
      Summary points:This CME activity reviews the costs of resistant epilepsy, describes an approach to pharmacoresistant epilepsy for the nonspecialist, reviews nonpharmacologic treatments and novel epilepsy therapies, and discuses which patients are candidates for epilepsy surgery.
      Accreditation:The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit. Expiration Date: June 30, 2011.
      Other:Text-only CME.


      Additional Information

      Audio:No
      Video:No
      Text:Yes
      Pictures/Slides:No
      Discussion group:No
      Feedback possible:No
      Minimum connection needed:28.8
      Plugins needed:No
      Registration:No


      Go to webcast/CME

      E-Mail this webcast/CME to a colleague

      Remind me of this



      All contents Copyright (c) 1995-2018 Doctor's Guide Publishing Limited. All rights reserved.